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The insulin receptor of human placenta even after extensive purification is phosphorylated in the presence 
of [y-32P]ATP and NaF, and is dephosphorylated again on incubation in NaF-free medium. Insulin 
stimulates phosphate incorporation into the M, 95 000 subunit probably by activation of the phosphoryla- 
tion step. Our data suggest hat the insulin receptor contains both kinase and phosphatase activities that 
may control the phosphorylation state of the receptor. 
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1. INTRODUCTION 
Studies on rat hepatoma cells and human 
lymphocytes [l], on normal rat hepatocytes [2], 
and also on solubilized preparations from rat liver 
membranes [2,3] indicate that the insulin receptor 
is liable to phosphorylation, and that insulin stimu- 
lates this reaction. Here, we show that the insulin 
receptor from human placenta undergoes also 
phosphorylation stimulatable by insulin, and that 
this property is maintained even after extensive 
purification of the receptor protein. Moreover, our 
studies suggest that the purified insulin receptor 
contains, in addition to kinase(s), tightly bound 
phosphatase(s) which catalyze(s) the dephosphory- 
lation reaction. As to the effect of insulin, evidence 
is presented that the hormone increases the rate of 
phosphorylation by activation of the kinase rather 
than by inhibition of the phosphatase. 
2. MATERIALS AND METHODS 
Chemicals and materials (sources in brackets): 
insulin, bovine, acrylamide, bisacrylamide (Serva, 
Heidelberg); Triton X-100, phenylmethanesulfonyl 
fluoride (PMSF), N-acetyl-D-glucosamine (Sigma, 
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St Louis); leupeptin(Prot. Res. Found. Osaka); ade- 
nosine 5’-[y-33P]triphosphate([y-32P]ATP) (NEN, 
Dreieichenhain); adenosine 5 ’ -triphosphate 
(ATP) (Boehringer, Mannheim); silver-stain kit, 
hydroxyapatite (Bio-Rad, Munchen); Sepharose 
6B-Cl (Pharmacia, Uppsala); polyethylene glycol 
6000 (PEG) (Roth, Karlsruhe); bovine serum 
albumin (BSA) (Calbiochem, GieBen). 
2.1. Assay of insulin binding activity (ZBA) 
Specific ?-insulin binding was determined as 
in [4] using dextrane-coated charcoal for separa- 
tion of free and bound ligand. In our standard 
assay 1 ng (=25 @) of 1251-insulin (kindly sup- 
plied by Novo, Copenhagen) was incubated in 
300 ~1 buffer for 45 min at 25°C at receptor con- 
centrations within the linear range. Specific IBA is 
expressed as mU/mg protein. 
Protein was determined by either biuret [S] or 
Lowry [6] procedure after precipitation with a 
20-fold volume of dioxane and washing of the pre- 
cipitate with 1 ml 10% trichloroacetic acid. 
Standard proteins (Bio-Rad, Munchen) for M, 
determination were (x 10e3): myosin (200); p- 
galactosidase (116); phosphorylase b (94); bovine 
serum albumin (68); ovalbumin (43). 
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2.2. Purification of the insulin receptor 
Membranes were prepared from fresh human 
placenta and extracted with 1.5% Triton X-100 
essentially as in [7]. HEPES was replaced by Tris, 
and leupeptin (10m6 M) and PMSF (lo-’ M) was 
present in the buffer solutions. IBA of the Triton 
extracts was 0.1-O. 15 mU/mg protein. 
2.3. Gel filtration on Sepharose 6B-Cl 
The 105 000 x g supernatant of solubilized mem- 
branes (-25 ml corresponding to 200-300 mg pro- 
tein) was passed over a Sepharose 6B-Cl column 
(4 x 100 cm) equilibrated with 50 mM Tris-HCl 
(pH 7.6) containing 0.1% Triton X-100 (T/T- 
buffer) at -0.5 ml/min. Fractions (10 ml) were 
collected, those with IBA were pooled and after 
adjusting to 10 mM MgC12 concentrated by pre- 
cipitation with PEG, final cont. 12.5% (IBA -1 
mU/mg protein). This fraction was rechromato- 
graphed on a Sepharose 6B-Cl column (2 x 170 
cm), concentrated by lyophilisation and precipi- 
tated with PEG as above (IBA -4 mU/mg 
protein). 
2.4. Sucrose density gradient centrifugation 
Preparations after gel filtration (corresponding 
to l-3 mg protein) were layered onto 12.5 ml 
5-20070 linear sucrose gradients in T/T-buffer, and 
centrifuged at 41000 rev./min at 4°C for 24 h (SW 
41 rotor, Beckman Model L5 65 ultracentrifuge). 
The receptor appeared in the first three 1 ml frac- 
tions collected from bottom (IBA -10 mU/mg 
protein). 
2.5. Chromatography on hydroxyapatite 
The fraction was applied on a hydroxyapatite 
column (1 x 4 cm), equilibrated with T/T-buffer. 
Unabsorbed protein together with sucrose was 
washed out with T/T-buffer. The receptor was 
eluted with 200 ml linear gradient of l-40 mM 
Na-phosphate buffer (pH 7.6) containing 0.1% 
Triton X-100. After lyophilisation the protein was 
taken up in a small volume of T/T buffer. This 
preparation (IBA -20 mU/mg protein) displayed 
apparent homogeneity of the M, 135 000 and 95 000 
receptor subunits on SDS-PAGE (fig. 1A). 
Fig. 1. Electrophoretic pattern of insulin receptor from 
human placenta. (A) Fraction after hydroxyapatite chro- 
matography. SDS-PAGE (14 pg protein) on 7.5% slab 
gel according to IS]. (B) Fraction as in (A) separated on 
3.75% polyacrylamide slab gel as in [8] except hat SDS 
was replaced in the gel and buffer by Triton X-100, final 
cont. 0.07%. In (a) 5 pg and (b) 10 pg of non-reduced 
protein was applied. In (A) and (B) proteins were local- 
ized by silver stain [9]. For elution of protein the frac- 
tion corresponding to the undissociated receptor (see B) 
was cut out from unstained parallel gels and homo- 
genized in a glass-teflon homogenizer with T/T-buffer. 
After centrifugation 50% of IBA with a specific activity 
of 40 mU/mg protein was recovered in the supernatant. 
2.6. Polyacrylamide gel electrophoresis gel as in fig. 1B. IBA of these preparations was 
Further purification was achieved by polyacryla- 30-40 mU/mg protein with a recovery from the gel 
mide slab gel electrophoresis and elution from the of 50%. 
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3. RESULTS AND DISCUSSION 
Placenta membranes are phosphorylated in a 
time-dependent manner on incubation with 
[y-32P]ATP (fig. 2). The rate of phosphate incor- 
poration is largely increased after solubilization of 
the membranes with Triton X-100 which also clear- 
ly enlarges the modest stimulatory effect of insulin 
seen with intact membranes. It appears that solu- 
bilization increases the number of phosphorylation 
sites of membrane proteins accessible to the action 
of protein kinase(s) - both insulin-dependent and 
-independent. The stimulation of phosphorylation 
of solubilized membranes was half maximal at 
lo-’ M insulin reaching the maximum at lo-* M. 
November 1982 
Fig. 2. Time course of “P incorporation in human 
placental membranes before ( q , m ) and after (0, l ) 
solubilization with Triton X-100. Membranes correspon- 
ding to 400 pg protein were suspended in a mixture of 
50mM Tris-HCl (pH 7.6), 12mM MgC12, 1 mM 
MnC12, 100 mM NaF, 5 mM DTT, 20 Kg BSA, and 
when added 0.1 PM insulin. If solubilized membranes 
were to be studied 1% Triton X-100 was included. After 
30 min preincubation at room temperature the samples 
were placed on ice and the reaction was started by addi- 
tion of [y-32P]ATP (-6 PCi) to give 12-15 PM final 
ATP cont. Samples were kept at O”C, and at the times 
indicated 45 ~1 aliquots were pipetted off for determina- 
tion of protein-bound radioactivity as described in [lo]: 
( 0 , 0) no insulin; ( n , l ) insulin added. 
Fig. 3. Autoradiogram of human placenta membrane 
phosphoproteins after gel filtration and SDS-poly- 
acrylamide gel electrophoresis. Membranes (50 mg pro- 
tein) were preincubated in the Triton X-100 containing 
medium described in fig. 1 in the absence (A) or presence 
(B) of insulin (10e7 M). [y-“P]ATP (250 &i, final 
cont. 15 PM) was added and incubation (at O’C) con- 
tinued for 10 min. Reaction was stopped by addition of 
EDTA, final cont. 25 mM. The receptor was purified on 
Sepharose 6B-Cl as described in the method section ex- 
cept that the first step was also done on the 2 x 170 cm 
column. The pooled peak fractions (200 gg protein) were 
mixed with rabbit serum containing insulin receptor an- 
tibodies (preparation to be described elsewhere), and 
precipitated with a second antibody (sheep anti-rabbit 
(IgG, Behring, Marburg)). The precipitate was 
resuspended and washed with trichloroacetic acid and 
further processed for SDS-PAGE as in fig. 1 and 
autoradiography on Kodak X-Omat films as in [ 111. 
98 
Volume 149, number 1 FEBS LETTERS November 1982 
KM app. for ATP was 3 PM (not shown). During 
chromatography of the phosphorylated membrane 
proteins on Sepharose 6B-Cl the peak of the radio- 
activity coincided with the peak of IBA (Mr 
350000), the specific radioactivity (cpm/mg pro- 
tein) being about twice as high after pre-treatment 
of membranes with insulin. Further evidence that 
the receptor protein is involved was obtained on 
examination by SDS-polyacrylamide gel elec- 
trophoresis and autoradiography (fig. 3). In agree- 
ment with [2] it is shown that it is the A4, 
95000-subunit of the insulin receptor whose phos- 
phorylation is stimulated by insulin under these 
conditions. 
Insulin-stimulated phosphorylation is demon- 
strable with receptor preparations carried through 
all purification steps up to the highest degree of 
purity. This is documented by the experiments 
shown in fig. 4 which were performed with ap- 
parently homogenous receptor preparations eluted 
from polyacrylamide gel after electrophoresis (see 
fig. 1B). Moreover, these experiments how that 
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Fig. 4. Effect of insulin on phosphorylation of highly 
purified insulin receptor in the presence (0,~) and 
absence (0, l ) of NaF: 9.5 pg electrophoretically 
purified insulin receptor (see section 2.6 and fig. 1B) 
dissolved in 400 ~1 solution composed of 50 mM 
Tris-HCl (pH 7.6), 12 mM MgCl2, 1 mM MnC12, 
5 mM DTT, 18 pg BSA, 0.1% Triton X-100, and where 
added 100 mM NaF. After preincubation (45 min, 
25°C) without ( W, 0) and with insulin (lo-’ M) 
( 0 , 0) the samples were placed on ice and after addi- 
tion of 20&i [T-~~P]ATP, final cont. 15pM, 
phosphorylation was studied as in fig. 1. 
phosphorylation is largely decreased at omission of 
NaF from the incubation suggesting that there is 
also a phosphatase(s) present. The failure of in- 
sulin to increase phosphate incorporation in the 
absence of NaF (fig. 4) would then suggest hat in- 
sulin enhances receptor phosphorylation by stimu- 
lation of kinase(s) rather than by inhibition of 
phosphatase(s). 
Fig. 5 illustrates that the phosphorylated insulin 
receptor is dephosphorylated again upon incuba- 
tion in NaF-free medium. This lends further sup- 
port to the assumption that besides a kinase(s) 
there is also a phosphatase(s) tightly associated 
with the receptor catalyzing a phosphorylation-de- 
phosphorylation cycle resembling the operation of 
some interconvertible nzyme systems. The failure 
Fig. 5. Phosphorylation-dephosphorylation of highly 
purified insulin receptor from human placenta. Receptor 
400 ~1 in T/T-buffer after hydroxyapatite chromato- 
graphy (28 mU/mg protein) (see section 2.5 and fig. 1A) 
corresponding to 54 pg protein was mixed with 155 ~1 
50 mM Tris-HCl (pH 7.6), 80 ~1 1 M NaF, 20 ~10.1 M 
MnCl2, 20 ~1 0.5 M MgCl2, 40 4 0.1 M DTT, 40 ~1 
0.5% BSA, 45 pl (5 $i) [y-32P]ATP (final cont. 
25 hM). After 8 min incubation at 0°C (0-O) two 
samples of 300 d each were taken and rapidly mixed 
with 200 ~150% PEG solution for receptor precipitation 
(-). After centrifugation the precipitates were washed 
twice with 250 ~1 20% PEG in the above phosphoryla- 
tion mixture except [T-~~P]ATP: (A) was resuspended in 
300~1 of the washing medium; in(B) NaF was omitted and 
replaced by medium. A (O---O) and B (O---O) were then 
further incubated at 0°C. Protein bound radioactivity 
was determined [lo] using 45 ~1 samples drawn at the 
times indicated on the abscissa. 
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of detecting these regulatory enzymes as distinct 
proteins (e.g., on SDS-PAGE) may be explained 
on presuming that either there are only few present 
or that they represent catalytically active domains 
of the receptor protein itself. 
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